Read e-book Obstructive Airway Diseases: Role of Lipid Mediators

Free download. Book file PDF easily for everyone and every device. You can download and read online Obstructive Airway Diseases: Role of Lipid Mediators file PDF Book only if you are registered here. And also you can download or read online all Book PDF file that related with Obstructive Airway Diseases: Role of Lipid Mediators book. Happy reading Obstructive Airway Diseases: Role of Lipid Mediators Bookeveryone. Download file Free Book PDF Obstructive Airway Diseases: Role of Lipid Mediators at Complete PDF Library. This Book have some digital formats such us :paperbook, ebook, kindle, epub, fb2 and another formats. Here is The CompletePDF Book Library. It's free to register here to get Book file PDF Obstructive Airway Diseases: Role of Lipid Mediators Pocket Guide.
Obstructive Airway Diseases: Role of Lipid Mediators: Medicine & Health Science Books @ tricananap.cf
Table of contents

Teichgraber V, et al. Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis. Nat Med. Molecular biomarkers in idiopathic pulmonary fibrosis. American journal of physiology. Lung Cell Mol Physiol. Yang K, Han X. Lipidomics: techniques, applications, and outcomes related to biomedical sciences. Trends Biochem Sci.

Shotgun lipidomics on high resolution mass spectrometers. Cold Spring Harb Perspect Biol. Automated lipid identification and quantification by multidimensional mass spectrometry-based shotgun lipidomics. Anal Chem. Southam AD, et al. Drug redeployment to kill leukemia and lymphoma cells by disrupting SCD1-mediated synthesis of monounsaturated fatty acids.

Cancer Res. McLaren DG, et al. An ultraperformance liquid chromatography method for the normal-phase separation of lipids. Anal Biochem. Sampaio JL, et al. Membrane lipidome of an epithelial cell line. Kuhn T, et al. Higher plasma levels of lysophosphatidylcholine are related to a lower risk of common cancers in a prospective metabolomics study. BMC Med.

Information

Piszcz J, et al. To treat or not to treat: metabolomics reveals biomarkers for treatment indication in chronic lymphocytic leukaemia patients. Chem Biol Interact. Wilson ID, et al. High resolution "ultra performance" liquid chromatography coupled to oa-TOF mass spectrometry as a tool for differential metabolic pathway profiling in functional genomic studies. J Proteome Res. Wang CZ, et al. Ultra-performance liquid chromatography and time-of-flight mass spectrometry analysis of ginsenoside metabolites in human plasma. Am J Chin Med. Raghu G, et al. Pedersen HK, et al.

Obstructive Airway Diseases : Role of Lipid Mediators - MedLib

Human gut microbes impact host serum metabolome and insulin sensitivity. Fahy E, et al. A comprehensive classification system for lipids. J Lipid Res. Ohnishi H, et al. Comparative study of KL-6, surfactant protein-a, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases. Oikonomidi S, et al. Matrix metalloproteinases in respiratory diseases: from pathogenesis to potential clinical implications. Curr Med Chem. Ollero M, et al. Plasma lipidomics reveals potential prognostic signatures within a cohort of cystic fibrosis patients.

Regulation of lung surfactant phospholipid synthesis and metabolism. Biochim Biophys Acta.


  • Obstructive Airway Disease - an overview | ScienceDirect Topics.
  • Find a copy in the library;
  • Midnight Special.
  • Asian Voices from Beantown!
  • Mediators of Inflammation;
  • Boundaries in Marriage.
  • Calculate the Opportunity Cost, Absolute Advantage, and Comparative Advantage.

Glycerophospholipids and glycerophospholipid-derived lipid mediators: a complex meshwork in Alzheimer's disease pathology. Prog Lipid Res. Guerrera IC, et al. A novel lipidomic strategy reveals plasma phospholipid signatures associated with respiratory disease severity in cystic fibrosis patients. Marien E, et al. Non-small cell lung cancer is characterized by dramatic changes in phospholipid profiles.

American Review of Respiratory Disease

Int J Cancer. Wanders RJ, et al. Peroxisomal fatty acid alpha- and beta-oxidation in health and disease: new insights. Adv Exp Med Biol. Lee ST, et al.

Key points

Global changes in lipid profiles of mouse cortex, hippocampus, and hypothalamus upon p53 knockout. Sci Rep. Autophagy in the light of sphingolipid metabolism. An overview of sphingolipid metabolism: from synthesis to breakdown. Scarpa MC, et al. Ceramide expression and cell homeostasis in chronic obstructive pulmonary disease.

Miao H, et al. Plasma lipidomics reveal profound perturbation of glycerophospholipids, fatty acids, and sphingolipids in diet-induced hyperlipidemia. Ishikawa M, et al.

Plasma and serum lipidomics of healthy white adults shows characteristic profiles by subjects' gender and age. Cai X, et al. Download references. ZSW was involved in drafting the manuscript or revising it critically for important intellectual content. All authors read and approved the final manuscript. Correspondence to Feng Yan. Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This file contains the plasma lipid profiles of individual lipid species were determined with lipidomics from 40 plasma samples; 22 from IPF patients with 18 controls.

Chronic Obstructive Pulmonary Diseases (COPD) - Pulmonology

Reprints and Permissions. Yan, F.

Identification of the lipid biomarkers from plasma in idiopathic pulmonary fibrosis by Lipidomics. BMC Pulm Med 17, doi Download citation. Search all BMC articles Search. Abstract Background Idiopathic pulmonary fibrosis IPF is an irreversible interstitial pulmonary disease featured by high mortality, chronic and progressive course, and poor prognosis with unclear etiology.

Results A total of individual blood lipid species were determined with lipidomics from the 40 plasma samples including 20 types of fatty acid, types of glycerolipids, types of glycerophospholipids, 47 types of sphingolipids, 46 types of sterol lipids, 7 types of prenol lipids, 3 types of saccharolipids, and 4 types of polyketides. Conclusions Our results provided vital information regarding lipid metabolism in IPF patients and more importantly, a few potentially promising biomarkers were firstly identified which may have a predictive role in monitoring and diagnosing IPF disease. Open Peer Review reports.

Table 1 Sample demographics of the study subjects Full size table. Full size image. Table 2 List of assigned statistically significantly lipid molecules and change trend of biomarkers on plasma lipid profile in positive ion mode after comparison of IPF patient samples to control samples Full size table.

Table 3 Differences in the lipid levels of eight-promising biomarkers under the influence of gender, smoking, and disease status. The statistical significance was determined by Mann-Whitney U -test Full size table.